These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 26382031)
21. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats. He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231 [TBL] [Abstract][Full Text] [Related]
22. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807 [TBL] [Abstract][Full Text] [Related]
24. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling. Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631 [TBL] [Abstract][Full Text] [Related]
25. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction. Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation. Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628 [TBL] [Abstract][Full Text] [Related]
27. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats. Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584 [TBL] [Abstract][Full Text] [Related]
28. Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-β1-Smad2/3 pathway. Gao RJ; Aikeremu N; Cao N; Chen C; Ma KT; Li L; Zhang AM; Si JQ BMC Cardiovasc Disord; 2024 Oct; 24(1):535. PubMed ID: 39367342 [TBL] [Abstract][Full Text] [Related]
29. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice. Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics. Lin J; Chen R; Liao H; Zhang Y; Zheng Z; Hong C Sci Rep; 2024 May; 14(1):12431. PubMed ID: 38816406 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response. Luan Y; Chao S; Ju ZY; Wang J; Xue X; Qi TG; Cheng GH; Kong F Int Immunopharmacol; 2015 May; 26(1):188-93. PubMed ID: 25601497 [TBL] [Abstract][Full Text] [Related]
32. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension. Sutendra G; Dromparis P; Bonnet S; Haromy A; McMurtry MS; Bleackley RC; Michelakis ED J Mol Med (Berl); 2011 Aug; 89(8):771-83. PubMed ID: 21809123 [TBL] [Abstract][Full Text] [Related]
33. The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension. Yamaguchi Y; Hosokawa S; Haraguchi G; Kajikawa Y; Sakurai M; Ishii T; Ando N; Morio T; Doi S; Furukawa T J Pharmacol Exp Ther; 2023 May; 385(2):88-94. PubMed ID: 36849413 [TBL] [Abstract][Full Text] [Related]
34. Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation. Wang G; Ma N; Meng L; Wei Y; Gui J Mol Cell Biochem; 2015 Dec; 410(1-2):207-13. PubMed ID: 26350566 [TBL] [Abstract][Full Text] [Related]
35. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330 [TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells. Li Y; Li L; Qian Z; Lin B; Chen J; Luo Y; Qu J; Raj JU; Gou D J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514810 [TBL] [Abstract][Full Text] [Related]
38. H Feng S; Chen S; Yu W; Zhang D; Zhang C; Tang C; Du J; Jin H Lab Invest; 2017 Mar; 97(3):268-278. PubMed ID: 27941756 [TBL] [Abstract][Full Text] [Related]
39. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823 [TBL] [Abstract][Full Text] [Related]
40. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70. Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]